The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma

Table 1

Clinical characteristics of the 12 HCC (a) and 10 LC (b) patients.

(a)  

Case number	Sex	Age	Stage	Child-Pugh	Tumor size (mm)	Differentiation	AFP (ng/mL)	PIVKA-II (mAU/mL)
H1	M	71	III	A	Multiple, max 30	Poorly	70.6	18
H2	M	73	IV	B	Multiple, max 50	Moderately	549.6	44
H3	F	69	III	A	38	Moderately–well	11.9	59
H4	M	73	III	B	32–30	Moderately	208.1	20
H5	M	69	III	B	29–25	Moderately–well	38.3	12
H6	F	77	III	A	Multiple, max30	Moderately–well	47.3	10
H7	M	67	III	A	30–10	Moderately	14.9	35
H8	F	71	III	B	35–20	Well	1031.7	466
H9	M	58	IV	B	20	Moderately	25.1	75
H10	F	71	III	B	30	Poorly–moderately	14640	<10
H11	M	81	III	A	25	Moderately	62.3	6854
H12	M	70	III	A	60	—	1390	5350

(b)  

Case number	Sex	Age	Child-Pugh	AFP (ng/mL)	PIVKA-II (mAU/mL)
L1	M	45	B	12	—
L2	F	54	A	36.4	<10
L3	M	59	A	24.3	31
L4	M	59	B	12.8	66
L5	F	62	A	4.5	—
L6	M	43	A	8.5	—
L7	M	48	B	11.3	—
L8	M	60	A	37.7	—
L9	F	68	A	15.3	—
L10	M	45	B	6	—